Cord Blood America Inc. today announced that their CEO, Matthew Schissler, was interviewed by the leading biotechnology publication in Greece, BIONOVA magazine. He spoke about his company, and the work they have been doing collecting, testing and processing umbilical cords in the United States. He also told the magazine that his company has been actively engaging in advertising through print, radio and television for further support of their cause.
Schissler told the magazine, “Stem cells are used today in the treatment of leukemia, breast cancer, lymphoma, Hodgkin’s Disease, aplastic anemia, sickle cell anemia, various other cancers, blood diseases, hereditary and genetic conditions and immune system disorders.” He also added the promising news; “As stem cell transplants become routine, they may be used to fight many other cancers, viruses and genetic disorders.”
“Umbilical cord stem cells are used to repopulate one’s immune system. An example would be a leukemia patient who undergoes radiation therapy. The stem cells from the umbilical cord repopulate the patient’s immune system with healthy cells to keep the body strong and to help fight other diseases,” said Cord Blood America’s CEO. He also explained that, “umbilical cord stem cells are a perfect match for the baby, but because of close genetic ties, there is a good chance they will match for immediate family members as well. They also may be a very good match for a sibling. Umbilical cord stem cells are the best because they have hematapoletic traits, meaning they repopulate the immune system and have regenerative traits meaning they can regenerate tissue.”
This interview was Cord Blood America’s first venture into the world of international business, and could be the first of many. Schissler never ruled out the potential for introducing the concept of collecting umbilical cords in other countries based upon the success the company has shown in the US.
Let us hear your thoughts: Cord Blood America Inc. Message Board